Experimental
Epidemiology
BY: JAGAN KUMAR OJHA
MSc. Tutor, SNC, Bhubaneswar
Experimental Studies
• Experimental studies are ones where researchers
introduce an intervention and study the effects
under the direct control of the investigator”
• The study in which an investigator manipulates or
controls one or more independent variables and
observes the effect on dependent variables.
Unique Features of Experiment
• Experiments provide strongest evidence about the
existence of a cause-effect relationship.
Aims of Experimental Epidemiology
❏ To provide “Scientific proof” of etiological or risk
factors which may permit the modification or control
of those diseases.
❏ To provide a method of measuring the effectiveness
and efficiency of health services for the prevention,
control and treatment of disease and improve the heath
of the community.
Randomized Controlled Trials
”An epidemiological experiment in which
subjects in a population are randomly allocated
into groups, usually called study and control
groups to receive and not receive an
experimental preventive or therapetuic
procedure, maneuver, or interventition”
John M.Last, 2001
Randomized Controlled Trials
• ”Gold standard” in epidemiological research
• Makes study groups comparable
• Prevents selection bias
Randomized Controlled Trials
Randomized
Controlled Trial
Design
Steps Involved In Randomized Controlled Trials Are
As Follows :
1. Drawing up a protocol
2. Selecting reference and experimental
populations( Study Population)
3. Randomization
4. Intervention or Manipulation
5. Follow up
6. Assessment of outcome
Drawing up a protocol
• Drawing up a Protocol specifies :
 Aims and objectives of study
 Questions to be answered
 Criteria for selection of study and control groups
 Size of the sample
 Procedures for allocation of subjects into study and
control groups
 Treatment to be applied-when ,where & how
 Schedules as well as responsibilities of parties
involved in the trial up to the outcome of the study
Drawing up a protocol…
Selecting reference and experimental
populations
• The experimental population is selected from the
reference population. The results of experimental
population if found successful, it is applied for the
reference population.
• Experimental population
• The actual group in which the trial is conducted
• Representive of the reference population
• Possibility for accurate follow up of information
during the trial( stable group )
Reference & Study Population
Reference
Population
Study
Population
Selection of study population
• Participants must be fully informed
- Purpose
- Procedure
• Risks
• Benefits
• Willing to participate
• Informed consent
• Screened for eligibility
• Inclusion criteria
• Exclusion criteria
Randomization is a statistical procedure by which
the participants are allocated into groups usually
called “Study” and “Control” groups, to receive or
not to receive an experimental, preventive or
therapeutic procedure or intervention.
Radomization
• Random = governed by chance
• Randomization = allocation of individuals to groups
by chance
• Each sampling unit has the same chance of selection
Radomization
Randomization
- Heart of the control trial
- Procedure: Participants are allocated into study
and control groups
- Both groups should be alike with regards to
certain variables that might affect the outcome of
the experiment
- Best done by using table of random numbers
Ensure comparability
Avoid selection bias
Why randomization is important?
 Intervene or manipulate the study group:
 Experimental group
• Application, withdrawal or reduction of suspected
causal factor
e.g. drug, vaccine, habit
 Control group
• no intervention, usual care, placebo
Intervention
Examination of experimental and control groups at
defined interval of time,
in a standard manner,
with equal intensity,
in the same time frame
until the final assesment of OUT COME
Follow-up
• Some losses to follow up are inevitable such as death,
migration, loss of interest- "Attrition "
• Possible reasons for non-adherence
• Developing side effects
• Forgetting to take medication
• Withdrawing consent
• Decide alternative treatment
• Health issues: treatment contraindicated
• Extent of non-adherence is related to length of study time
Attrition:
This is the final step of the trial. The outcome may
be positive or negative. During the assessment of the
outcome, bias is inevitable.
Positive (Benifits) and Negative (side effects etc..)
results are compared in both groups.
If there is difference, Test of Significance is applied
to find out the significance.
Assessment
BIAS ARISE FROM ERRORS OF ASSESMENT OF THE OUTCOME
Study Designs
 Parallel study design
Cross- over type of study design
 Parallel Study Design
 Parallel Study Design
 Cross-Over Study Design
 Cross-Over Study Design
Types of Randomized controlled trials
Clinical trials
Preventive trials
Risk factor trials
Cessation experiments
Trial of etiological agents
Evaluation of health services
1. Clinical Trial
- Concerned with evaluating therapeutic agent,
mainly drugs
eg. Evaluation of beta-blockers in reducing
cardiovascular mortality
2. Preventive Trials:
- Trial of primary preventive measures eg.
Vaccines
- Analysis of preventive trials must result in clear
statement about benefits to community, risk
involved and cost to health
3. Risk Factor Trials:
- Investigator intervenes to interrupt the usual
sequence in the development of disease for
those individuals who have risk factor for
developing the disease
- Primary prevention of CHD using clofibrate to
lower serum cholesterol
4. Cessation Experiment:
- An attempt is made to evaluate the termination
of a habit which is considered to be causally
related to disease
- Cigarette smoking and lung cancer
5. Trials of Etiological Agents:
- To confirm or refute an etiological hypothesis
6. Evaluation of Health Services:
- To evaluate effectiveness and efficiency of health
services
- Domiciliary treatment of Pulmonary Tuberculosis was as
effective as the more costlier hospital or sanatorium
treatment
• Ethical issues
• Feasibility
• Problems of finding sufficiently large eligible
sample size
• Costs
• Expensive
Unique problemes of intervetion studies
APPLICATION OF
EPIDEMIOLOGY
 To describe the spectrum of disease.
 To describe the natural history of disease.
 To formulate Community Diagnosis
 To Describe the clinical picture of a disease
 To Identify the factors that increase or decrease of disease
 To Identify precursor of disease & syndrome
 Test the efficacy of intervention strategies
 Investigation the epidemic of unknown disease
 Evaluate public health programme
 Elucidate the mechanism of disease transmission
ANY
DOUBT?
SUMMARY
THANK YOU

Experimental epidemiology

  • 1.
    Experimental Epidemiology BY: JAGAN KUMAROJHA MSc. Tutor, SNC, Bhubaneswar
  • 2.
    Experimental Studies • Experimentalstudies are ones where researchers introduce an intervention and study the effects under the direct control of the investigator” • The study in which an investigator manipulates or controls one or more independent variables and observes the effect on dependent variables.
  • 3.
    Unique Features ofExperiment • Experiments provide strongest evidence about the existence of a cause-effect relationship.
  • 4.
    Aims of ExperimentalEpidemiology ❏ To provide “Scientific proof” of etiological or risk factors which may permit the modification or control of those diseases. ❏ To provide a method of measuring the effectiveness and efficiency of health services for the prevention, control and treatment of disease and improve the heath of the community.
  • 6.
  • 7.
    ”An epidemiological experimentin which subjects in a population are randomly allocated into groups, usually called study and control groups to receive and not receive an experimental preventive or therapetuic procedure, maneuver, or interventition” John M.Last, 2001 Randomized Controlled Trials
  • 8.
    • ”Gold standard”in epidemiological research • Makes study groups comparable • Prevents selection bias Randomized Controlled Trials
  • 9.
  • 10.
    Steps Involved InRandomized Controlled Trials Are As Follows : 1. Drawing up a protocol 2. Selecting reference and experimental populations( Study Population) 3. Randomization 4. Intervention or Manipulation 5. Follow up 6. Assessment of outcome
  • 11.
    Drawing up aprotocol • Drawing up a Protocol specifies :  Aims and objectives of study  Questions to be answered  Criteria for selection of study and control groups  Size of the sample
  • 12.
     Procedures forallocation of subjects into study and control groups  Treatment to be applied-when ,where & how  Schedules as well as responsibilities of parties involved in the trial up to the outcome of the study Drawing up a protocol…
  • 13.
    Selecting reference andexperimental populations • The experimental population is selected from the reference population. The results of experimental population if found successful, it is applied for the reference population.
  • 14.
    • Experimental population •The actual group in which the trial is conducted • Representive of the reference population • Possibility for accurate follow up of information during the trial( stable group )
  • 15.
    Reference & StudyPopulation Reference Population Study Population
  • 16.
    Selection of studypopulation • Participants must be fully informed - Purpose - Procedure • Risks • Benefits • Willing to participate • Informed consent • Screened for eligibility • Inclusion criteria • Exclusion criteria
  • 17.
    Randomization is astatistical procedure by which the participants are allocated into groups usually called “Study” and “Control” groups, to receive or not to receive an experimental, preventive or therapeutic procedure or intervention. Radomization
  • 18.
    • Random =governed by chance • Randomization = allocation of individuals to groups by chance • Each sampling unit has the same chance of selection Radomization
  • 19.
    Randomization - Heart ofthe control trial - Procedure: Participants are allocated into study and control groups - Both groups should be alike with regards to certain variables that might affect the outcome of the experiment - Best done by using table of random numbers
  • 20.
    Ensure comparability Avoid selectionbias Why randomization is important?
  • 21.
     Intervene ormanipulate the study group:  Experimental group • Application, withdrawal or reduction of suspected causal factor e.g. drug, vaccine, habit  Control group • no intervention, usual care, placebo Intervention
  • 22.
    Examination of experimentaland control groups at defined interval of time, in a standard manner, with equal intensity, in the same time frame until the final assesment of OUT COME Follow-up
  • 23.
    • Some lossesto follow up are inevitable such as death, migration, loss of interest- "Attrition " • Possible reasons for non-adherence • Developing side effects • Forgetting to take medication • Withdrawing consent • Decide alternative treatment • Health issues: treatment contraindicated • Extent of non-adherence is related to length of study time Attrition:
  • 24.
    This is thefinal step of the trial. The outcome may be positive or negative. During the assessment of the outcome, bias is inevitable. Positive (Benifits) and Negative (side effects etc..) results are compared in both groups. If there is difference, Test of Significance is applied to find out the significance. Assessment BIAS ARISE FROM ERRORS OF ASSESMENT OF THE OUTCOME
  • 25.
    Study Designs  Parallelstudy design Cross- over type of study design
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
    Types of Randomizedcontrolled trials Clinical trials Preventive trials Risk factor trials Cessation experiments Trial of etiological agents Evaluation of health services
  • 31.
    1. Clinical Trial -Concerned with evaluating therapeutic agent, mainly drugs eg. Evaluation of beta-blockers in reducing cardiovascular mortality
  • 32.
    2. Preventive Trials: -Trial of primary preventive measures eg. Vaccines - Analysis of preventive trials must result in clear statement about benefits to community, risk involved and cost to health
  • 33.
    3. Risk FactorTrials: - Investigator intervenes to interrupt the usual sequence in the development of disease for those individuals who have risk factor for developing the disease - Primary prevention of CHD using clofibrate to lower serum cholesterol
  • 34.
    4. Cessation Experiment: -An attempt is made to evaluate the termination of a habit which is considered to be causally related to disease - Cigarette smoking and lung cancer
  • 35.
    5. Trials ofEtiological Agents: - To confirm or refute an etiological hypothesis 6. Evaluation of Health Services: - To evaluate effectiveness and efficiency of health services - Domiciliary treatment of Pulmonary Tuberculosis was as effective as the more costlier hospital or sanatorium treatment
  • 36.
    • Ethical issues •Feasibility • Problems of finding sufficiently large eligible sample size • Costs • Expensive Unique problemes of intervetion studies
  • 45.
    APPLICATION OF EPIDEMIOLOGY  Todescribe the spectrum of disease.  To describe the natural history of disease.  To formulate Community Diagnosis  To Describe the clinical picture of a disease  To Identify the factors that increase or decrease of disease  To Identify precursor of disease & syndrome  Test the efficacy of intervention strategies  Investigation the epidemic of unknown disease  Evaluate public health programme  Elucidate the mechanism of disease transmission
  • 46.
  • 47.
  • 48.

Editor's Notes

  • #32 Phase I: dose-finding Phase II: preliminary evidence of efficacy Phase III: comparisons to standard therapy Phase IV: post-marketing surveillance